Thoratec (THOR) Begins Heartmate III U.S. Clinical Trial
Tweet Send to a Friend
Thoratec Corporation (NASDAQ: THOR) announced today that it has begun to enroll patients in the HeartMate IIIā¢ U.S. clinical trial ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE